SIGN grades of recommendation
| Grades of recommendations | |
|---|---|
| A | At least one meta-analysis, systematic review or RCT rated as 1++, and directly applicable to the target population; or A body of evidence consisting principally of studies rated as 1+, directly applicable to the target population, and demonstrating overall consistency of results |
| B | A body of evidence including studies rated as 2++, directly applicable to the target population, and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 1++ or 1+ |
| C | A body of evidence including studies rated as 2+, directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2++ |
| D | Evidence level 3 or 4; or Extrapolated evidence from studies rated as 2+ |
| Good practice points | |
| ✓ | Recommended best practice based on the clinical experience of the Guideline Development Group |
RCT, randomised controlled trial; SIGN, Scottish Intercollegiate Guideline Network.